Target intelligence / Profile preview

Potassium-chloride cotransporter 1 (KCC1)

Target
KCC1
Molecular classification
Transporter, Solute carrier family (SLC), Cation-chloride cotransporter
01

Overview

The potassium-chloride cotransporter 1 (KCC1) is a membrane protein predominantly expressed in erythrocytes and other cells, responsible for the electroneutral symport of K^+ and Cl^- ions across the plasma membrane. KCC1 plays a central role in regulating cell volume, maintaining ionic balance, and ensuring proper intracellular chloride concentrations. In red blood cells, its overactivity contributes to cell dehydration and sickling in sickle cell disease. KCC1 belongs to the cation-chloride cotransporter family (SLC12), with isoforms KCC1–4 sharing structural features. KCC transport is tightly regulated by phosphorylation and cellular conditions such as swelling, acidification, and oxygenation state[1][2][4][6]. KCC1 function is implicated in the pathophysiology of hematological disorders and tumor progression, making it a potential but not yet clinically targeted therapeutic protein[1][4].

Other names
K-Cl cotransporter 1KCl cotransporter 1Solute carrier family 12 member 4SLC12A4Erythrocyte KCl cotransporter
02

Mechanism of action

Inhibition or modulation of K-Cl ion symport (potential mechanism for investigational drugs, no approved drugs targeting specifically)

03

Biological functions

Cell volume regulationIonic and osmotic homeostasisMaintenance of intracellular chloride concentrationErythroid maturation
04

Disease associations

Sickle cell diseaseCancerOther red cell disorders
05

Safety considerations

Disruption may lead to red cell dehydrationaltered cell volumeneurologicaland renal effects
06

Biomarkers

Overactivity or expression level in sickle cell diseasepossibly in certain cancers

Beyond the preview

Go deeper on Potassium-chloride cotransporter 1 (KCC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium-chloride cotransporter 1 (KCC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call